D.P. Dearnaley

3.2k total citations
56 papers, 2.2k citations indexed

About

D.P. Dearnaley is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, D.P. Dearnaley has authored 56 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 25 papers in Surgery and 10 papers in Molecular Biology. Recurrent topics in D.P. Dearnaley's work include Testicular diseases and treatments (18 papers), Prostate Cancer Treatment and Research (15 papers) and Prostate Cancer Diagnosis and Treatment (14 papers). D.P. Dearnaley is often cited by papers focused on Testicular diseases and treatments (18 papers), Prostate Cancer Treatment and Research (15 papers) and Prostate Cancer Diagnosis and Treatment (14 papers). D.P. Dearnaley collaborates with scholars based in United Kingdom, United States and Belgium. D.P. Dearnaley's co-authors include A. Horwich, Robert Huddart, J. Nicholls, A. Norman, Roger A’Hern, Maryam Shahidi, Doris D. Coward, H. J. G. Bloom, Sean Whittaker and N. Alsanjari and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Physiology and JNCI Journal of the National Cancer Institute.

In The Last Decade

D.P. Dearnaley

55 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D.P. Dearnaley United Kingdom 25 1.3k 743 454 378 378 56 2.2k
Hélène Martelli France 30 2.0k 1.5× 1.5k 2.1× 615 1.4× 595 1.6× 260 0.7× 132 3.9k
Carl W. Langberg Norway 23 875 0.7× 555 0.7× 407 0.9× 384 1.0× 244 0.6× 45 2.0k
Hege Sagstuen Haugnes Norway 22 1.3k 1.0× 455 0.6× 421 0.9× 578 1.5× 454 1.2× 82 2.1k
Jan Oldenburg Norway 23 1.7k 1.3× 713 1.0× 595 1.3× 381 1.0× 518 1.4× 76 2.4k
Jakob Eberhard Sweden 35 873 0.7× 370 0.5× 855 1.9× 920 2.4× 303 0.8× 128 3.2k
Marianne Brydøy Norway 18 735 0.6× 283 0.4× 275 0.6× 263 0.7× 461 1.2× 38 1.3k
Yoshiaki Tsuchida Japan 28 1.3k 0.9× 593 0.8× 691 1.5× 276 0.7× 75 0.2× 122 2.4k
W. David J. Ryder United Kingdom 30 731 0.5× 995 1.3× 623 1.4× 1.3k 3.5× 151 0.4× 64 3.1k
Maya Lodish United States 34 1.5k 1.1× 418 0.6× 1.0k 2.3× 505 1.3× 84 0.2× 130 3.9k
Sylvie Salenave France 34 1.3k 0.9× 168 0.2× 665 1.5× 169 0.4× 559 1.5× 83 3.6k

Countries citing papers authored by D.P. Dearnaley

Since Specialization
Citations

This map shows the geographic impact of D.P. Dearnaley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.P. Dearnaley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.P. Dearnaley more than expected).

Fields of papers citing papers by D.P. Dearnaley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.P. Dearnaley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.P. Dearnaley. The network helps show where D.P. Dearnaley may publish in the future.

Co-authorship network of co-authors of D.P. Dearnaley

This figure shows the co-authorship network connecting the top 25 collaborators of D.P. Dearnaley. A scholar is included among the top collaborators of D.P. Dearnaley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.P. Dearnaley. D.P. Dearnaley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murray, Julia, et al.. (2015). PO-0736: Bladder and trigone surface doses are related to acute urinary toxicity in focally dose-escalated prostate IMRT. Radiotherapy and Oncology. 115. S364–S365. 1 indexed citations
2.
Horwich, A., Sophie D. Fosså, Robert Huddart, et al.. (2013). Second cancer risk and mortality in men treated with radiotherapy for stage I seminoma. British Journal of Cancer. 110(1). 256–263. 59 indexed citations
3.
Sohaib, S.A., Dow‐Mu Koh, Yolanda Barbáchano, et al.. (2008). Prospective assessment of MRI for imaging retroperitoneal metastases from testicular germ cell tumours. Clinical Radiology. 64(4). 362–367. 60 indexed citations
4.
Hafeez, S., Ricky A. Sharma, Robert Huddart, D.P. Dearnaley, & A. Horwich. (2006). Challenges in Treating Patients with Down's Syndrome and Testicular Cancer with Chemotherapy and Radiotherapy: The Royal Marsden Experience. Clinical Oncology. 19(2). 135–142. 7 indexed citations
5.
Williams, Horace R., Panagiotis Vlavianos, Peter Blake, et al.. (2005). The significance of rectal bleeding after pelvic radiotherapy. Alimentary Pharmacology & Therapeutics. 21(9). 1085–1090. 25 indexed citations
6.
Dearnaley, D.P.. (2003). A Double-Blind, Placebo-Controlled, Randomized Trial of Oral Sodium Clodronate for Metastatic Prostate Cancer (MRC PR05 Trial). JNCI Journal of the National Cancer Institute. 95(17). 1300–1311. 174 indexed citations
7.
Bevan, Steve, Stephen M. Edwards, Anna Dowe, et al.. (2003). Germline mutations in fumarate hydratase (FH) do not predispose to prostate cancer. Prostate Cancer and Prostatic Diseases. 6(1). 12–14. 10 indexed citations
8.
Dearnaley, D.P., et al.. (2001). Managing testicular cancer. BMJ. 322(7302). 1583–1588. 108 indexed citations
9.
Dearnaley, D.P.. (2001). Radiotherapy and combined modality approaches in localised prostate cancer. European Journal of Cancer. 37. 137–145. 9 indexed citations
10.
Nutting, Christopher M., Vincent Khoo, H. McNair, et al.. (2000). A randomised study of the use of a customised immobilisation system in the treatment of prostate cancer with conformal radiotherapy. Radiotherapy and Oncology. 54(1). 1–9. 40 indexed citations
11.
Norman, A., et al.. (2000). True. British Journal of Cancer. 82(12). 1952–1957. 23 indexed citations
12.
', Mason, Peter R. Malone, Noel W. Clarke, et al.. (1999). The Royal College of Radiologists' Clinical Oncology Information Network. British Association of Urological Surgeons. Guidelines on the management of prostate cancer.. PubMed. 11(2). S53–88. 30 indexed citations
13.
Edwards, Stephen M., W.D. Dunsmuir, Cheryl Gillett, et al.. (1998). Immunohistochemical expression of BRCA2 protein and allelic loss at theBRCA2 locus in prostate cancer. International Journal of Cancer. 78(1). 1–7. 26 indexed citations
14.
Huddart, Robert, Balakrishnan Rajan, Matthew Law, Lesley Meyer, & D.P. Dearnaley. (1997). Spinal cord compression in prostate cancer: treatment outcome and prognostic factors. Radiotherapy and Oncology. 44(3). 229–236. 44 indexed citations
15.
Fernández, Eduardo, et al.. (1997). The potential for increased sparing of normal tissue in parallel opposed techniques with a multileaf collimator. Clinical Oncology. 9(5). 330–333. 1 indexed citations
16.
Thomas, R., et al.. (1996). An analysis of surveillance for stage I combined teratoma - seminoma of the testis. British Journal of Cancer. 74(1). 59–62. 8 indexed citations
17.
SHEARER, R. J., et al.. (1994). Induction of transforming growth factor beta in hormonally treated human prostate cancer. British Journal of Cancer. 69(1). 130–134. 31 indexed citations
18.
HENDRY, W. F., Roger A’Hern, John Hetherington, et al.. (1993). Para‐aortic Lymphadenectomy after Chemotherapy for Metastatic Non‐seminomatous Germ Cell Tumours: Prognostic Value and Therapeutic Benefit. British Journal of Urology. 71(2). 208–213. 75 indexed citations
19.
Horwich, A., N. Alsanjari, Roger A’Hern, et al.. (1992). Surveillance following orchidectomy for stage I testicular seminoma. British Journal of Cancer. 65(5). 775–778. 146 indexed citations
20.
Dearnaley, D.P., Roger A’Hern, Sean Whittaker, & H. J. G. Bloom. (1990). Pineal and CNS germ cell tumors: royal marsden hospital experience 1962–1987. International Journal of Radiation Oncology*Biology*Physics. 18(4). 773–781. 148 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hélène Martelli Breakdown of academic impact, for papers by Carl W. Langberg Breakdown of academic impact, for papers by Hege Sagstuen Haugnes Breakdown of academic impact, for papers by Jan Oldenburg Breakdown of academic impact, for papers by Jakob Eberhard Breakdown of academic impact, for papers by Marianne Brydøy Breakdown of academic impact, for papers by Yoshiaki Tsuchida Breakdown of academic impact, for papers by W. David J. Ryder Breakdown of academic impact, for papers by Maya Lodish Breakdown of academic impact, for papers by Sylvie Salenave
Rankless by CCL
2026